NanoVibronix (STU:56R0) Days Sales Outstanding : 131.49 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is NanoVibronix Days Sales Outstanding?

NanoVibronix's average Accounts Receivable for the three months ended in Sep. 2024 was €0.49 Mil. NanoVibronix's Revenue for the three months ended in Sep. 2024 was €0.34 Mil. Hence, NanoVibronix's Days Sales Outstanding for the three months ended in Sep. 2024 was 131.49.

The historical rank and industry rank for NanoVibronix's Days Sales Outstanding or its related term are showing as below:

STU:56R0' s Days Sales Outstanding Range Over the Past 10 Years
Min: 8.77 Med: 31.43 Max: 70.93
Current: 39.46

During the past 13 years, NanoVibronix's highest Days Sales Outstanding was 70.93. The lowest was 8.77. And the median was 31.43.

STU:56R0's Days Sales Outstanding is ranked better than
84.26% of 813 companies
in the Medical Devices & Instruments industry
Industry Median: 65.03 vs STU:56R0: 39.46

NanoVibronix's Days Sales Outstanding increased from Sep. 2023 (10.21) to Sep. 2024 (131.49).

NanoVibronix Days Sales Outstanding Historical Data

The historical data trend for NanoVibronix's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoVibronix Days Sales Outstanding Chart

NanoVibronix Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

70.40

43.13

24.09

47.55

26.15

NanoVibronix Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															10.21	13.62	33.56	47.19	131.49

Competitive Comparison of NanoVibronix's Days Sales Outstanding

For the Medical Devices subindustry, NanoVibronix's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NanoVibronix's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NanoVibronix's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where NanoVibronix's Days Sales Outstanding falls into.

NanoVibronix Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

NanoVibronix's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.008	+	0.292)	/	2 )	/	2.094	*	365
=	0.15					/	2.094	*	365
=	26.15

NanoVibronix's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (0.454	+	0.523)	/	2 )	/	0.339	*	365 / 4
=	0.4885					/	0.339	*	365 / 4
=	131.49

NanoVibronix (STU:56R0) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

NanoVibronix Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of NanoVibronix's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

NanoVibronix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NanoVibronix Inc (STU:56R0) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

NAOV:USA

Address

969 Pruitt Avenue, Tyler, TX, USA, 77569

Website

https://www.nanovibronix.com

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.

NanoVibronix Headlines

No Headlines